View in Browser | View in Mobile.
Practical Diabetes
 
Dear Colleague,

Read the latest articles from Practical Diabetes from the links below or visit our website at www.practicaldiabetes.com for archived content and additional resources and links.

Professor Ken Shaw
Editor in Chief


Integrating technology into adolescent care
The fascination of adolescents with new technology offers an attractive option for clinical teams to use it to try to improve diabetes control in youth. But are any of the technologies successful in influencing adherence in this challenging group? William Lamb explores the topic.


Outcomes in children managed on CSII
Continuous subcutaneous insulin infusion (CSII) has become increasingly popular among patients with type 1 diabetes but does evidence show improved diabetes control? Tafadzwa Makaya et al look at data from the Sheffield Children’s Hospital to see whether the point at which comparisons of HbA1c were made affected the impact of CSII on diabetes control.


  Test your knowledge and prepare for the SCE
Year of Care – the key drivers
Conversations in consultations are reported to be a source of frustration but if personalised results are utilised and goals given which encourage the seeking of information, this can lead to significantly lower HbA1c levels. Yvonne Doherty describes the revolutionary Year of Care initiative which proposes changing the annual review into a collaborative care planning consultation.


Prevalence of type 2 diabetes in young people in East London
Newham has one of the highest prevalence of T2DM in the UK as well as one of the youngest populations. Anjali Balasanthiran et al investigate what the exact prevalence of T2DM is in this community and the characteristics in comparison to existing data.


Cardio-renal protection for adolescents with type 1 diabetes
There is no clear guidance on the use of drugs such as angiotensin converting enzyme inhibitors (ACEIs) and/or statins in young people with type 1 diabetes. David Dunger et al discuss the objectives behind the pioneering AdDIT trial which is the first multicentre, multinational RCT assessing the efficacy of ACEIs and statins in adolescents, the results of which may shape future treatment of this high risk group.



 
You can unsubscribe by emailing us at e-news@wiley.com with the subject line unsubscribe <emailaddr>.

We will ALWAYS respect your e-mail privacy and NEVER sell, rent, or exchange your address to any outside company. For complete details, review our Privacy Policy (www.wiley.com/privacy) .
AMERICAS  
(Corporate Headquarters)
John Wiley & Sons
111 River Street
Hoboken, NJ 07030-5774
USA

Phone: 877-762-2974
EUROPE

The Atrium
Southern Gate, Chichester
West Sussex PO19 8SQ
England

Phone: +44 (0) 1243 843294
ASIA

John Wiley & Sons Singapore Pte Ltd
1 Fusionopolis Walk #07-01
Solaris South Tower
Singapore 138628

Phone: +65 6302-9838

CANADA

John Wiley & Sons, Inc.
5353 Dundas Street West, Suite 400
Toronto, Ontario M9B 6H8
Canada

Phone: 416.236.4433
AUSTRALIA

John Wiley & Sons Pte Ltd
155 Cremorne Street
Richmond, Victoria 3121
Australia

Phone: +61 07 3354 8444
John Wiley & Sons
John Wiley & Sons, Inc., Publishers - www.wiley.com
customer@wiley.com

HSJ-12-43708